Boothbay Fund Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Boothbay Fund Management's RGEN Position: Q3 2026 in Review
Boothbay Fund Management increased its Repligen (RGEN) stake by 138% in Q3 2026, buying an estimated $5.5M and bringing the position to 58,307 shares worth $11.2M. The position accounts for 0.18% of the portfolio, ranked #125.
Boothbay Fund Management first reported a position in RGEN in Q3 2019 and has held it in 4 quarters since. 525 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Boothbay Fund Management held 58,307 shares of Repligen worth $11.2M as of Q3 2026.
- Boothbay Fund Management bought 33,842 Repligen shares in Q3 2026, an estimated $5.5M.
- Repligen made up 0.18% of Boothbay Fund Management's portfolio in Q3 2026, its #125 holding.
- Boothbay Fund Management first reported a position in Repligen in Q3 2019 and has held it in 4 quarters since.
- 525 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.